Search research articles
Contact Us
Filters
Showing results (131-140 of 347) with videos related to
Page
of 35
Sort By:
Frontiers in Oncology
|
November 3, 2022
How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study
Angélique Da Silva, Aude Fléchon, Elodie Coquan, et al.
Cancer Medicine
|
July 26, 2023
Does COVID-19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital
Florian Quilan, Justine Lequesne, François Cherifi, et al.
Cancers
|
March 29, 2023
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
Stéphane Culine, Valentin Harter, Clémentine Krucker, et al.
European Journal of Cancer Care
|
March 28, 2020
Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based study
Ariane Mamguem Kamga, Agnès Dumas, Florence Joly, et al.
Bulletin Du Cancer
|
January 23, 2026
[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]
Yann Neuzillet, Constance Thibault, Loïc Mourey, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 20, 2013
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial
Béatrice Weber, Rémy Largillier, Isabelle Ray-Coquard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 14, 2010
Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015)
Jean-Léon Lagrange, Caroline Bascoul-Mollevi, Lionnel Geoffrois, et al.
BMC Cancer
|
May 24, 2017
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study
Alison C Johnson, Margarida Matias, Helen Boyle, et al.
Clinical Genitourinary Cancer
|
June 11, 2016
Clinical Benefit of Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma: The French Retrospective SECTOR Study
Stéphane Oudard, Florence Joly, Lionnel Geoffrois, et al.
BMC Cancer
|
February 19, 2018
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
Marina Pulido, Guilhem Roubaud, Anne-Laure Cazeau, et al.
Page
of 35
Search research articles
Search
Showing results (131-140 of 347) with videos related to
Sort By:
Page
of 35
Frontiers in Oncology
|
November 3, 2022
How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study
Angélique Da Silva, Aude Fléchon, Elodie Coquan, et al.
Cancer Medicine
|
July 26, 2023
Does COVID-19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital
Florian Quilan, Justine Lequesne, François Cherifi, et al.
Cancers
|
March 29, 2023
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
Stéphane Culine, Valentin Harter, Clémentine Krucker, et al.
European Journal of Cancer Care
|
March 28, 2020
Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based study
Ariane Mamguem Kamga, Agnès Dumas, Florence Joly, et al.
Bulletin Du Cancer
|
January 23, 2026
[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]
Yann Neuzillet, Constance Thibault, Loïc Mourey, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 20, 2013
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial
Béatrice Weber, Rémy Largillier, Isabelle Ray-Coquard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 14, 2010
Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015)
Jean-Léon Lagrange, Caroline Bascoul-Mollevi, Lionnel Geoffrois, et al.
BMC Cancer
|
May 24, 2017
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study
Alison C Johnson, Margarida Matias, Helen Boyle, et al.
Clinical Genitourinary Cancer
|
June 11, 2016
Clinical Benefit of Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma: The French Retrospective SECTOR Study
Stéphane Oudard, Florence Joly, Lionnel Geoffrois, et al.
BMC Cancer
|
February 19, 2018
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
Marina Pulido, Guilhem Roubaud, Anne-Laure Cazeau, et al.
Page
of 35